\(
\def\WIPO{World Intellectual Property Organisation}
\)
Biotechnology and Software Patent Law : a comparative review of new developments.
2011
G 252 ARE.B
Available at WIPO Library
Items
Details
Title
Biotechnology and Software Patent Law : a comparative review of new developments.
Author
Description
360 pages ; 24 cm.
ISBN
9781849800402 Print
9780857938039 eBook
9780857938039 eBook
Alternate Call Number
G 252 ARE.B
Summary
The new millennium has carried several challenges for patent law. This up-to-date book provides readers with an important overview of the most critical issues patent law is still facing today at the beginning of the twenty first century, on both sides of the Atlantic. New technological sectors have emerged, each one with its own features with regard to innovation process and pace. From the most controversial cases in biotech to the most recent decisions in the field of software and business methods patent, patent law has tried to stretch its boundaries in a way to accommodate such new and controversial subject matters into its realm. Biotechnology and Software Patent Law will strongly appeal to postgraduate students specializing in IP law, international law, commercial and business law and competition law, as well as IP scholars, academics and lawyers.
Bibliography, etc. Note
Includes bibliographical references and index.
Formatted Contents Note
Introduction
PART I: GENERAL THEMES IN PATENT LAW
1. Tailoring Patents to Different Industries. 2. Innovation in the New Technological Industries: Looking for a Consistent Cooperative Model. 3. The Future of the Requirement for an Invention: Inherent Patentability as a Pre- and Post-Patent Determinant. 4. The Experimental Use of the Patented Invention: A Free Use or an Infringing Use? 5. Patents and Competition Law: Some Features of the New Interface
PART II: EMERGING THEMES IN INFORMATION TECHNOLOGIES - 6. Are Software Patents Something Special? 7. Towards a New Instrument of Protection for Software in the EU? Learning the Lessons from the Harmonization Failure of Software Patentability. 8. Patent Governance in the United States: Lessons from Bilski v. Kappos
PART III: EMERGING THEMES IN THE BIOTECH INDUSTRIES - 9. A Decade After the Birth of the Biotech Directive: Was it Worth the Trouble? 10. Gene Patents Under Fire: Weighing the Costs and Benefits. 11. Patentability of Human Stem Cell or Synthetic Biology Based Inventions. 12. Moral Limits to Biotech Patents in Europe: A Quest for Higher Harmonization
Index
PART I: GENERAL THEMES IN PATENT LAW
1. Tailoring Patents to Different Industries. 2. Innovation in the New Technological Industries: Looking for a Consistent Cooperative Model. 3. The Future of the Requirement for an Invention: Inherent Patentability as a Pre- and Post-Patent Determinant. 4. The Experimental Use of the Patented Invention: A Free Use or an Infringing Use? 5. Patents and Competition Law: Some Features of the New Interface
PART II: EMERGING THEMES IN INFORMATION TECHNOLOGIES - 6. Are Software Patents Something Special? 7. Towards a New Instrument of Protection for Software in the EU? Learning the Lessons from the Harmonization Failure of Software Patentability. 8. Patent Governance in the United States: Lessons from Bilski v. Kappos
PART III: EMERGING THEMES IN THE BIOTECH INDUSTRIES - 9. A Decade After the Birth of the Biotech Directive: Was it Worth the Trouble? 10. Gene Patents Under Fire: Weighing the Costs and Benefits. 11. Patentability of Human Stem Cell or Synthetic Biology Based Inventions. 12. Moral Limits to Biotech Patents in Europe: A Quest for Higher Harmonization
Index
Series
New directions in patent law.
Location
Z01 02 HC 47811
Linked Resources
Published
Cheltenham : Edward Elgar, 2011.
Language
English
Record Appears in